BTCC
/
BTCC Square
/
Global Cryptocurrency
/
AstraZeneca Wins Shareholder Approval for Direct NYSE Listing
AstraZeneca Wins Shareholder Approval for Direct NYSE Listing
18
2
BTCCSquare news:
AstraZeneca's strategic pivot to the U.S. market gained momentum as 99.36% of shareholders endorsed plans for a direct New York Stock Exchange listing. The pharmaceutical giant will replace its American Depositary Receipts with ordinary shares starting February 2, while maintaining its primary London listing.
The MOVE harmonizes the company's listing structures across London, Stockholm, and New York. Chair Michel Demaré emphasized the decision will unlock access to deeper capital pools, particularly in the critical U.S. market where ordinary shares offer voting rights and lower fees compared to ADRs.
By:
